The Medicines Company Reports Second-Quarter and First-Half 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
Buy The Medicines Company (MDCO) on Weakness, Guggenheim Says
July 29, 2015 11:25 AM EDTGuggenheim analyst Louise Chen is out defending The Medicines Company (NASDAQ: MDCO) amid today's weakness following the company's 2Q15 miss. Shares are down 5% to $31.84 currently.
Chen commented, "This was not surprising to us, since customers have held back on ordering Angiomax this year in anticipation of the launch of cheaper, generic versions of... More
Medicines Co. (MDCO) Misses Q2 EPS by 23c
July 29, 2015 7:27 AM EDTMedicines Co. (NASDAQ: MDCO) reported Q2 EPS of ($0.71), $0.23 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $90.5 million versus the consensus estimate of $122.58 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
... More